Displaying 51 - 60 of 70
Active Status: No
User: Female
Mode: No
Delivery Type: Oral
Developer: Innolytics LLC
Project Stage: Lead Optimization
Alternative Name: Proprotein convertase 6
Target
Active Status: Unknown
Mode: No
Developer: CONRAD, Prince Henry's Institute of Medical Research, Australia
Role in reproduction: Implantation
Project Stage: Target Validation
Alternative Name: Phosphodiesterase 3, 5, 9, PDE3A
Target
Active Status: Yes
User: Female
Mode: No
Developer: Oregon Health & Science University, University of Minnesota
Role in reproduction: Oocyte Maturation
Project Stage: Target Identification
Active Status: Yes
User: Female
Mode: No
Delivery Type: Vaginal Gel, Vaginal Ring
Developer: Ottawa Hospital Research Institute (OHRI)
Project Stage: Lead Optimization
Active Status: No
User: Female
Mode: Yes
Delivery Type: Vaginal Gel
Developer: Vindico NanoBio Technology Inc.
Project Stage: Lead Optimization
Alternative Name: PGE2
Target
Active Status: Yes
User: Female
Mode: No
Developer: Oregon Health & Science University, Bayer HealthCare
Role in reproduction: Oocyte Maturation
Project Stage: Target Identification
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal Gel, Other
Project Stage: Compound ID/Selection
Alternative Name: Retinoic acid receptor (RAR) antagonists
Target
Active Status: Yes
User: Male
Mode: No
Developer: NICHD, Columbia University, University of Washington, University of Minnesota
Role in reproduction: Spermatogenesis
Project Stage: Target Validation
Alternative Name: l-CDB-4022
User: Male
Mode: No
Delivery Type: Oral
Project Stage: Lead Optimization
Alternative Name: Serum- and Glucocorticoid-Regulated Kinase
Target
Active Status: Unknown
User: Female
Mode: No
Developer: CONRAD, Imperial College, London
Role in reproduction: Implantation
Project Stage: Target Identification
Pages
